Compare Heron Therapeutics Inc (HRTX) vs Roundhill Russell 2000 0DTE Covered Call Strat ETF (RDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $28.82. The key difference: Roundhill Russell 2000 0DTE Covered Call Strat ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | RDTE | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $1.96 | $34.72 |
52-Week Low | $0.39 | $26.40 |
Enterprise Value | $189.36M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
RDTE trades at $28.57, down 0.38% with a bearish technical signal. The stock exhibits high dividend activity but lacks disclosed valuation and profitability ratios. Recent news highlights structural risks in its covered call strategy, with concerns about capital erosion despite high yields. Trading near support at $28, the stock faces selling pressure from moving averages while oscillators show neutral to oversold conditions.
The outlook remains cautious due to unresolved fundamental metrics and negative analyst sentiment. Investment opportunities hinge on dividend sustainability, but risks include capped upside from the options strategy and potential NAV deterioration. Investors require clearer financial disclosures to assess true value amid bearish technical and media coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Roundhill Russell 2000 0DTE Covered Call Strat ETF
RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →
